Letairis (Gilead Sciences, Inc)
Welcome to the PulseAid listing for the Letairis drug offered from Gilead Sciences, Inc. This Endothelin Receptor Antagonist [EPC],Endothelin Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Gilead Sciences, Inc |
| NON-PROPRIETARY NAME: | AMBRISENTAN |
| SUBSTANCE NAME: | AMBRISENTAN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Endothelin Receptor Antagonist [EPC],Endothelin Receptor Antagonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2007-06-15 |
| END MARKETING DATE: | 0000-00-00 |
Letairis HUMAN PRESCRIPTION DRUG Details:
| Item Description | Letairis from Gilead Sciences, Inc |
| LABELER NAME: | Gilead Sciences, Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 2007-06-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 61958-0801_bb56fca3-fff9-4212-ba49-4959ad5a269e |
| PRODUCT NDC: | 61958-0801 |
| APPLICATION NUMBER: | NDA022081 |
Other AMBRISENTAN Pharmaceutical Manufacturers / Labelers:
